On December 17, the U.S. Food and Drug Administration (FDA) finalized its long-awaited guidance on the “Use of Real-World Evidence…
Read More →
Texas’ SB 6, signed earlier this year, establishes a statutory framework for managing the growth of large loads in the…
Read More →
For those operating in the European Union, the list of digital technology laws is becoming daunting. Compliance with GDPR to…
Read More →
The Securities and Exchange Commission (“SEC”) published a Frequently Asked Questions (“FAQs”) page focusing on trade and settlement issues, requested…
Read More →
On Dec. 10, 2025, the FDA announced that, as a result of the ongoing investigations into the contamination of ByHeart…
Read More →
While the drugs we take are supposed to help us, sometimes they do more harm than good. If you have…
Read More →
The SEC’s Division of Examinations (the “Division”) recently announced its examination priorities (“Exam Priorities”) for fiscal year 2026. In this…
Read More →
Artificial intelligence (AI) has rapidly transitioned from a niche analytical tool to a core component of modern investment management. Asset…
Read More →
The Ninth Circuit has affirmed a trademark injunction in iyO, Inc. v. IO Products, Inc., a case that underscores how…
Read More →
In a bold shift toward centralized oversight of artificial intelligence (AI), the White House is reportedly preparing an executive order…
Read More →